These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 22913714)
21. [Fungal infections in children with malignant disease]. Michel G Arch Pediatr; 2011 May; 18 Suppl 1():S3-7. PubMed ID: 21596284 [TBL] [Abstract][Full Text] [Related]
22. Safety of triazole antifungal drugs in patients with cancer. Cronin S; Chandrasekar PH J Antimicrob Chemother; 2010 Mar; 65(3):410-6. PubMed ID: 20035021 [TBL] [Abstract][Full Text] [Related]
23. Fungemia due to Rhodotorula mucilaginosa after allogeneic hematopoietic stem cell transplantation. Mori T; Nakamura Y; Kato J; Sugita K; Murata M; Kamei K; Okamoto S Transpl Infect Dis; 2012 Feb; 14(1):91-4. PubMed ID: 21535337 [TBL] [Abstract][Full Text] [Related]
24. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases]. Karthaus M; Böhme A Wien Med Wochenschr; 2001; 151(3-4):80-8. PubMed ID: 11789423 [TBL] [Abstract][Full Text] [Related]
25. Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination. Perkhofer S; Lass-Flörl C Expert Opin Investig Drugs; 2009 Sep; 18(9):1393-404. PubMed ID: 19656074 [TBL] [Abstract][Full Text] [Related]
26. Successful treatment of disseminated Fusariosis after allogeneic hematopoietic stem cell transplantation with the combination of voriconazole and liposomal amphotericin B. Stanzani M; Vianelli N; Bandini G; Paolini S; Arpinati M; Bonifazi F; Giannini B; Agostinelli C; Baccarani M; Ricci P J Infect; 2006 Dec; 53(6):e243-6. PubMed ID: 16584783 [TBL] [Abstract][Full Text] [Related]
27. [New aspects in treatment of systemic mycoses]. Presterl E; Graninger W Wien Klin Wochenschr; 1998 Nov; 110(21):740-50. PubMed ID: 9871965 [TBL] [Abstract][Full Text] [Related]
28. Overview of treatment options for invasive fungal infections. Pound MW; Townsend ML; Dimondi V; Wilson D; Drew RH Med Mycol; 2011 Aug; 49(6):561-80. PubMed ID: 21366509 [TBL] [Abstract][Full Text] [Related]
29. [Amphotericin B: the end of an era]. Oude Lashof AM; Kullberg BJ Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1665-8. PubMed ID: 15453116 [TBL] [Abstract][Full Text] [Related]
30. The safety of interferon-gamma-1b therapy for invasive fungal infections after hematopoietic stem cell transplantation. Safdar A; Rodriguez G; Ohmagari N; Kontoyiannis DP; Rolston KV; Raad II; Champlin RE Cancer; 2005 Feb; 103(4):731-9. PubMed ID: 15641032 [TBL] [Abstract][Full Text] [Related]
31. Treatment of systemic fungal infections in older patients: achieving optimal outcomes. Kauffman CA; Hedderwick SA Drugs Aging; 2001; 18(5):313-23. PubMed ID: 11392440 [TBL] [Abstract][Full Text] [Related]
32. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation. Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of amphotericin B lipid complex injection (ABLC) in bone marrow transplant recipients with life-threatening systemic mycoses. Wingard JR Bone Marrow Transplant; 1997 Feb; 19(4):343-7. PubMed ID: 9051244 [TBL] [Abstract][Full Text] [Related]
34. Lipid formulations of amphotericin B: clinical perspectives for the management of invasive fungal infections in children with cancer. Groll AH; Müller FM; Piscitelli SC; Walsh TJ Klin Padiatr; 1998; 210(4):264-73. PubMed ID: 9743964 [TBL] [Abstract][Full Text] [Related]